Financhill
Buy
60

HIMS Quote, Financials, Valuation and Earnings

Last price:
$34.74
Seasonality move :
3.58%
Day range:
$32.68 - $36.27
52-week range:
$11.20 - $72.98
Dividend yield:
0%
P/E ratio:
66.57x
P/S ratio:
5.76x
P/B ratio:
16.75x
Volume:
23.4M
Avg. volume:
28.5M
1-year change:
150.52%
Market cap:
$8B
Revenue:
$1.5B
EPS (TTM):
$0.54

HIMS Analysts' Consensus Rating

The 13 analysts providing 12-month price projections for Hims & Hers Health shares anticipate an average target of $43.43, ranging from a low estimate of $21.00 to a high estimate of $85.00. This average target implies a growth of 20.8% compared to the current stock price of $35.95.

Consensus Price Target

$43.43

Highest Price Target

$85.00

Lowest Price Target

$21.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 5 4 4

Hold 8 7 8

Sell 0 1 1
Consensus Hold Hold Hold

HIMS Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

IBM Stock: Stable Dividend or Stagnant Investment?
IBM Stock: Stable Dividend or Stagnant Investment?

The AI race has heated up significantly but returns on…

Is Trimble Stock a Buy, Sell or Hold?
Is Trimble Stock a Buy, Sell or Hold?

Trimble (NASDAQ:TRMB) is a hardware and software tech company that…

Is DraftKings Stock a Good Bet on the Future of Sports Betting?
Is DraftKings Stock a Good Bet on the Future of Sports Betting?

It seems like right now is a good time to…

Stock Ideas

Buy
62
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 36x

Alerts

Buy
86
WLDN alert for Mar 10

Willdan Group [WLDN] is down 3.66% over the past day.

Buy
76
PDEX alert for Mar 10

Pro-Dex [PDEX] is up 10.33% over the past day.

Sell
7
IOT alert for Mar 10

Samsara [IOT] is down 3.68% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock